AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 79 filers reported holding AKEBIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $12,018,000 | +81.1% | 836,337 | +40.0% | 1.38% | +109.3% |
Q1 2015 | $6,637,000 | -4.5% | 597,363 | 0.0% | 0.66% | -11.8% |
Q4 2014 | $6,953,000 | -47.4% | 597,363 | 0.0% | 0.75% | -52.2% |
Q3 2014 | $13,220,000 | -20.4% | 597,363 | 0.0% | 1.56% | -6.9% |
Q2 2014 | $16,601,000 | – | 597,363 | – | 1.68% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alerce Investment Management, L.P. | 16,205,119 | $18,473,836 | 31.57% |
ACADIAN ASSET MANAGEMENT LLC | 7,223,488 | $8,233 | 0.04% |
Orchard Capital Management, LLC | 66,826 | $76,182 | 0.03% |
XTX Topco Ltd | 138,506 | $157,897 | 0.03% |
State of Wyoming | 74,010 | $84,371 | 0.02% |
WEALTH EFFECTS LLC | 29,500 | $33,630 | 0.02% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 1,719,061 | $1,959,730 | 0.01% |
James J. Burns & Company, LLC | 24,542 | $28 | 0.01% |
Eudaimonia Partners, LLC | 27,144 | $30,945 | 0.01% |
SYKON CAPITAL LLC | 15,000 | $17,100 | 0.01% |